ArticleJournal of cellular and molecular medicine2017

The V2 receptor antagonist tolvaptan raises cytosolic calcium and prevents AQP2 trafficking and function: an in vitro and in vivo assessment.

Grazia Tamma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.